Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety and Efficacy of the Percutaneous Left Ventricular Assist System Versus ECMO for Intraoperative Circulatory Support During High-risk Percutaneous Coronary Intervention (PCI): a Prospective, Multi-center, Randomized Controlled Study

NCT06639321 is registered in ClinicalTrials.gov with Shanghai NewMed Medical Co., Ltd. as lead sponsor.

NCT NCT06639321
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06639321 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety and Efficacy of the Percutaneous Left Ventricular Assist System Versus ECMO for Intraoperative Circulatory Support During High-risk Percutaneous Coronary Intervention (PCI): a Prospective, Multi-center, Randomized Controlled Study
Lead sponsor
Shanghai NewMed Medical Co., Ltd.
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 14, 2024
Completion date
October 14, 2026
Enrollment
250 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease